11:36 AM EDT, 10/20/2025 (MT Newswires) -- RedHill Biopharma ( RDHL ) said Monday Cumberland Pharmaceuticals (CPIX) will invest $4 million for a 30% ownership stake in RedHill's global Talicia business.

The companies will share in the financial performance and operational support for the Talicia brand, RedHill said. Talicia is approved for the treatment of helicobacter pylori infection.

RedHill also said the deal would help it regain compliance with Nasdaq's minimum stockholders' equity requirement.

RedHill shares were up over 18% in recent trading, while Cumberland was up almost 1%.

Price: 3.47, Change: +0.03, Percent Change: +0.78